Inhibiting angiogenesis by oral immunisation with poly(1-caprolactone)- poly(ethylene glycol)-poly(1-caprolactone) nanoparticle-encapsulated basic fibroblast growth factor

Volume: 6, Issue: 4, Pages: 221 - 225
Published: May 19, 2011
Abstract
Attempts to neutralise basic fibroblast growth factor (BFGF) have met some success in blocking neovascularisation. The authors describe an oral protein vaccine based on human BFGF encapsulated poly(e-caprolactone)epoly(ethylene glycol)epoly(e-caprolactone) (PCEC) nanoparticles. The human BFGF encapsulated PCEC nanoparticles (BFGF/PCEC) were monodisperse with the mean diameter of 142enm and can slow-released BFGF in vitro . After mice were...
Paper Details
Title
Inhibiting angiogenesis by oral immunisation with poly(1-caprolactone)- poly(ethylene glycol)-poly(1-caprolactone) nanoparticle-encapsulated basic fibroblast growth factor
Published Date
May 19, 2011
Volume
6
Issue
4
Pages
221 - 225
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.